Diuretics and RAAS Antagonists Use in Heart Failure Flashcards

1
Q

HF Pharmacotherapy Goals

A

1) Reduction of Congestion- Diuretics
2) Modulate Neurohormonal activation- RAAS antagonists and B-Blockers- Positive Remodeling
3) Improve flow- Vasodilators (difficult to obtain pharmacotherapeutically)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chronic HFrEF Treatments

A
BB
ACEI/ARB
Aldosterone antagonist
Hydralazine / ISDN
\+/- Digoxin
ICD/CRT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic HFpEF Treatments

A

Unknown
Control Risk Factors (DM, HTN, obesity)
Control volume status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acute HFrEF Treatments

A
No standard treatment
IV Diuresis
Nitrates (if BP allows)
CPAP (if SOB)
Pressors (if very depressed cardiac output/shock)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute HFpEF Treatments

A

No standard treatment
IV diuresis
Nitrates (if BP allows)
CPAP/BiPAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Preferred Type of Diuretics. Reason. Specific Drugs.

A

Loop Diuretics are preferred because of EFFICACY. Can be augmented with a thiazide diuretic. Used Chronically and acutely. Furosemide (lasix) is the most common. Torsemide and bumetanide have more reliable absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ACEIs.

A

Produce vasodilation and decreased aldosterone activation

Plus antiremodeling effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ARBs. Use?

A

Used in patients intolerant to ACEIs (most often cough due to Bradykinin breakdown product)

NO apparent benefit from dual therapy with ACEI and ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aldosterone Antagonists. Use and functions?

A

Added to therapy for LVEF < 30-35%, optimized on ACEI/ARB and β-blocker therapy. Blocks aldosterone effect on kidney. Antiremodeling action plus produces additional Na+ loss at the kidney.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diuretics (we need to know).

A

Hydrocholothiazide
Furosemide (Lasix)
Spironolactone (Aldactone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diuretic general location of action and mechanisms.

A

Exert effects at lumenal (urine) surface of renal tubule cells.
Work by:
1) Interactions with membrane transport proteins (thiazides, furosemide)
2) Interactions with enzymes (acetazolamide) or hormone receptors (spironolactone)
3) Osmotic effects preventing water reabsorption (mannitol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Na+ movement is controlled by?

A

Na+-K+ ATPase activity at the interstitial (blood) surface. In the kidney, Na+-K+-ATPase produces gradient necessary for Na+ reabsorption from the urine back into the blood. No diuretics work against the Na-K-ATPase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Loop Diuretic Example(s)

A

Furosemide (variable bioavailability)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Potassium Wasting Agent(s)

A

Loop Agents

Thiazides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Potassium Sparing Agent(s)

A

Aldosterone Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Furosemide Blocks…? Causes increased excretion of…?

A

NKCC2. Na-K-Cl Cotransporter. Decreases Sodium transport across membrane (Urine to Blood). Also, decreases potassium transport back into Urine (decreased membrane potential) which blocks magnesium and calcium transport. Leads to increased H20 excretion as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TAL

A

Thick Ascending Limb of Loop of Henle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Loop Diuretics effect on blood flow and diuretic effects on patients with decreased renal function.

A

Increase renal blood flow via effect on renin-angiotensin and prostaglandin systems
Retain substantial diuretic effect even if renal function is compromised (CrCl < 50 ml/min)
Handled by glomerular filtration and renal secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Loop Diuretics Use? Enhanced by?

A
  • Used in HF patients with volume overload to eliminate symptoms of fluid retention
  • Efficacy is enhanced with salt restriction (< 2 g/day)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pt’s with HF have reduced…..

A

Diuretic Response! Decreased drug delivery to kidney via decreased RBF. Hypoperfusion activates of RAAS and SNS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Most common use of a thiazide

A

Refractory Edema! Synergistic effect with Loop Diuretics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Thiazide Purpose

A

Block distal tubule sodium reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aldosterone Antagonist Improves? Functions?

A

Improves survival of some patients with HF. Enhances diuresis and ameliorates the potassium wasting at the collecting tubule (CT)

24
Q

Most efficacious diuretic in HF?

A

LOOP DIURETICS!! (High-ceiling dose drug)

25
Q

LD’s Adverse Reactions

A

Hypokalemic metabolic alkalosis (predisposes to ectopic pacemakers and arrhythmias)
Hyperuricemia (may precipitate a gout attack)

26
Q

Loop and Thiazide Potassium effect?

A

Synergistic Potassium excretion!

27
Q

Thiazides block

A

NCC cotransporter (Na and Cl). Decreases Sodium transport (increased excretion) and increased Ca2+ reabsorption (decreased serum Ca2+ levels). MODEST diuretic effect (only 5 to 10% of Na is reabsorbed at the distal tubule).

28
Q

Methods to increase loop diuretic efficacy?

A
  • Increase initial dose of furosemide
  • Switch to bumetanide or torsemide = more reliable bioavailability and longer duration of action
  • IV administration may be required initially due to congestion-related interference with oral absorption
29
Q

ACEI Dosing Timeframe?

A

Started during or after optimization of diuretic therapy

Initiated at low doses and titrated to goal

30
Q

Aldosterone Antagonist Monitoring? Specific drugs?

A

Monitor for Hyperkalemia and kidney function.

Spironolactone preferred if tolerated - if endocrine side effects occur, Eplerenone can be used.

31
Q

Prototypical Thiazide and dose

A

Hydrochlorothiazide

once or twice daily dose

32
Q

Thiazide Adverse Reactions

A

Hypokalemia- predisposition to ectopic pacemakers!
Hyperuricemia- avoid in patients with gout
Hyperglycemia
Hyperlipidemia
2° hyperaldosteronism
Allergic reactions: skin rashes occasionally, related to SULFONAMIDE STRUCTURE!

33
Q

Aldosterone Signal?

A

Decreased Blood Volume

34
Q

Aldosterone Effects?

A

Receptor increases concentration of ENaC (channels) in lumenal membrane and Na/K ATPase in interstitium membrane.

35
Q

Aldosterone Antagonist Blocks…?

A

Binds Aldosterone receptor, blocks activity and decreases Na/Fluid reabsorption. MILD diuretic effect (only 2-5% Na reabsorption at collecting duct)

36
Q

Benefit of Eplerenone over Spironolactone?

A

Decreased Gynecomastia (no man boobs!). Lower affinity for androgen and progesterone receptor.

37
Q

Triamterene/Amiloride

A

NO UTILITY IN HF! direct block of Na channels in collecting duct.

38
Q

Spironolactone/Eplerenone Dosing

A

1-2 doses/day for both. Must wait for turnover of receptors to become effective.

39
Q

Most important action of Spironolactone in HF is?

A

Block of aldo receptors on heart- acts as a RAAS antagonist rather than a diuretic. ANTI-REMODELING action (decreased hypertrophy and fibrosis)! Also, increases potassium to counter arrhythmias from K+ wasting diuretics.

40
Q

K+ sparing diuretic adverse reactions

A

1) Hyperkalemia- EKG changes, conduction abnormalities, arrhythmias. Increased risk with age, underlying renal dysfunction, higher dosage, use with ACEI/ARB and usage of NSAIDS.
2) Endocrine Abnormalities (gynecomastia) with spironolactone via block of androgen receptor (not with eplerenone)

41
Q

Targets of RAAS antagonists

A

AT-1 receptor, ACE, and Aldosterone receptor.

42
Q

ACE produces?

A

Angiotensin II from Angiotensin I and inactivates Bradykinin (may cause vasodilation)

43
Q

ACE effects?

A

AT-1 @ vessels produces vasoconstriction. AT-1 @ kidneys produces increased aldosterone.

44
Q

Breakdown of Bradykinin may result in?

A

Cough!

45
Q

ACEI’s vs ARBs

A

Same effects but cough won’t occur w/ ARBs. (Pril to Sartan with cough). Both RAAS antagonists. Elevated Potassium with both!

46
Q

Vasodilators vs ACEIs

A

Vasodilators have less survival benefits than ACEIs in HF.

47
Q

ACEI/Aldosterone blockers Effect in HF

A

Moderates myocardial hypertrophy and remodeling

48
Q

ACEI Bradykinin Effect

A

Decreases bradykinin inactivation, increasing its vasodilator action

49
Q

ACEI Prodrug Examples and Mechanism

A

lisinopril and captopril. De-esterification in liver to active metabolite.

50
Q

ACEI Potential Side Effects

A
Hyperkalemia
Hypotension
Decreased Renal Function
Chronic Dry Cough
CATEGORY D DURING PREGNANCY!
51
Q

Positives of ARBs vs ACEIs

A

1) More complete inhibition of Ang II (not all pathways are blocked by ACEIs)
2) No side effects due to increased Bradykinin levels (cough, angioedema)

52
Q

Negatives of ARBs vs ACEIs

A

1) Loss of increased BK vasodilation seen with ACEIs

2) Only Ang II actions at AT-1 receptors are blocked

53
Q

ARB Dosing

A

Once daily dosing (except losartan x 2 daily)

Decreased losartan dose necessary in hepatic dysfunction

54
Q

ARB Side Effects

A

Similar to ACEI, contraindicated in pregnancy

NO angioedema or cough, which are thought to be bradykinin-mediated

55
Q

Thiazide Example(s)

A

Hydrochlorothiazide

56
Q

Aldosterone Antagonist Example(s)

A

Spironolactone and Eplerenone